Abstract
The transcription factor brachyury (TBXT in humans) promotes epithelial-mesenchymal transition (EMT) both during gastrulation and in cancer contexts and is widely used as a marker of nascent mesoderm. In their study, Benoit Bruneau and colleagues reveal the role of TBXT dosage in early human gastrulation. To know more about their work, we spoke to the first author, Emily Bulgar, and the corresponding author, Benoit Bruneau, Professor at the Department of Pediatrics, University of California San Francisco (UCSF) and Director of the Gladstone Institute of Cardiovascular Disease.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
